Heterogeneous Arterial Healing in Patients Following Paclitaxel-Eluting Stent Implantation. Comparison With Sirolimus-Eluting Stents

JACC: Cardiovascular Interventions

Volumn 2, Issue 5, 2009, Pages 453-458

  Awata, Masaki ^a   Nanto, Shinsuke ^b   Uematsu, Masaaki ^a   Morozumi, Takakazu ^a   Watanabe, Tetsuya ^a   Onishi, Toshinari ^a   Iida, Osamu ^a   Sera, Fusako ^a   Minamiguchi, Hitoshi ^a   Kotani, Jun ichi ^b   Nagata, Seiki ^a  

^a KANSAI ROSAI HOSPITAL   (Japan)

^b OSAKA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

angioscope; imaging; neointima; stent

Indexed keywords

ACETYLSALICYLIC ACID; PACLITAXEL; RAPAMYCIN; TICLOPIDINE; ANTINEOPLASTIC AGENT; ANTITHROMBOCYTIC AGENT;

ADULT; AGED; ANGIOSCOPY; ARTICLE; ATHEROSCLEROTIC PLAQUE; CLINICAL ARTICLE; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DRUG ELUTING STENT; FEMALE; HUMAN; IMPLANTATION; IN-STENT RESTENOSIS; MALE; PRIORITY JOURNAL; STENT THROMBOSIS; WOUND HEALING; ANGIOCARDIOGRAPHY; COMPARATIVE STUDY; CORONARY BLOOD VESSEL; DRUG EFFECTS; MIDDLE AGED; PATHOLOGY; RESTENOSIS; RETROSPECTIVE STUDY; VASCULAR ENDOTHELIUM; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; ANTINEOPLASTIC AGENTS, PHYTOGENIC; ASPIRIN; CORONARY ANGIOGRAPHY; CORONARY ARTERY DISEASE; CORONARY RESTENOSIS; CORONARY VESSELS; DRUG-ELUTING STENTS; ENDOTHELIUM, VASCULAR; FEMALE; HUMANS; MALE; MIDDLE AGED; PACLITAXEL; PLATELET AGGREGATION INHIBITORS; RETROSPECTIVE STUDIES; TICLOPIDINE;

EID: 65649115891     PISSN: 19368798     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jcin.2009.03.005     Document Type: Article

References (24)

1. Moses J.W., Leon M.B., Popma J.J., et al. Sirolimus-eluting stents versus standard stents in patients with stenosis in a native coronary artery. N Engl J Med 349 (2003) 1315-1323
2. Stone G.W., Ellis S.G., Cox D.A., et al. One-year clinical results with the slow-release, polymer-based, paclitaxel-eluting TAXUS stent: the TAXUS-IV trial. Circulation 109 (2004) 1942-1947
3. Pfisterer M., Brunner-La Rocca H.P., Buser P.T., et al. Late clinical events after clopidogrel discontinuation may limit the benefit of drug-eluting stents: an observational study of drug-eluting versus bare-metal stents. J Am Coll Cardiol 48 (2006) 2584-2591
4. Stone G.W., Moses J.W., Ellis S.G., et al. Safety and efficacy of sirolimus- and paclitaxel-eluting coronary stents. N Engl J Med 356 (2007) 998-1008
5. Lagerqvist B., James S.K., Stenestrand U., Lindback J., Nilsson T., and Wallentin L. Long-term outcomes with drug-eluting stents versus bare-metal stents in Sweden. N Engl J Med 356 (2007) 1009-1019
6. Kastrati A., Mehilli J., Pache J., et al. Analysis of 14 trials comparing sirolimus-eluting stents with bare-metal stents. N Engl J Med 356 (2007) 1030-1039
7. Farb A., Burke A.P., Kolodgie F.D., and Virmani R. Pathological mechanisms of fatal late coronary stent thrombosis in humans. Circulation 108 (2003) 1701-1706
8. Finn A.V., Joner M., Nakazawa G., et al. Pathological correlates of late drug-eluting stent thrombosis: strut coverage as a marker of endothelialization. Circulation 115 (2007) 2435-2441
9. Awata M., Kotani J., Uematsu M., et al. Serial angioscopic evidence of incomplete neointimal coverage after sirolimus-eluting stent implantation: comparison with bare-metal stents. Circulation 116 (2007) 910-916
10. Takano M., Mizuno K., Yokoyama S., et al. Changes in coronary plaque color and morphology by lipid-lowering therapy with atorvastatin: serial evaluation by coronary angioscopy. J Am Coll Cardiol 42 (2003) 680-686
11. Sakai S., Mizuno K., Yokoyama S., et al. Morphologic changes in infarct-related plaque after coronary stent placement: a serial angioscopy study. J Am Coll Cardiol 42 (2003) 1558-1565
12. Haase J., Escaned J., van Swijndregt E.M., et al. Experimental validation of geometric and densitometric coronary measurements on the new generation Cardiovascular Angiography Analysis System (CAAS II). Cathet Cardiovasc Diagn 30 (1993) 104-114
13. Kotani J., Awata M., Nanto S., et al. Incomplete neointimal coverage of sirolimus-eluting stents: angioscopic findings. J Am Coll Cardiol 47 (2006) 2108-2111
14. Awata M., Nanto S., Uematsu M., et al. Angioscopic comparison of neointimal coverage between zotarolimus- and sirolimus-eluting stents. J Am Coll Cardiol 52 (2008) 789-790
15. den Heijer P., Foley D.P., Hillege H.L., et al. The "Ermenonville" classification of observations at coronary angioscopy-evaluation of intra- and inter-observer agreement. Eur Heart J 15 (1994) 815-822
16. Ueda Y., Asakura M., Yamaguchi O., Hirayama A., Hori M., and Kodama K. The healing process of infarct-related plaques. Insights from 18 months of serial angioscopic follow-up. J Am Coll Cardiol 38 (2001) 1916-1922
17. Mauri L., Orav E.J., Candia S.C., Cutlip D.E., and Kuntz R.E. Robustness of late lumen loss in discriminating drug-eluting stents across variable observational and randomized trials. Circulation 112 (2005) 2833-2839
18. Schomig A., Dibra A., Windecker S., et al. A meta-analysis of 16 randomized trials of sirolimus-eluting stents versus paclitaxel-eluting stents in patients with coronary artery disease. J Am Coll Cardiol 50 (2007) 1373-1380
19. Stettler C., Wandel S., Allemann S., et al. Outcomes associated with drug-eluting and bare-metal stents: a collaborative network meta-analysis. Lancet 370 (2007) 937-948
20. Miyamoto A., Prieto A.R., Friedl S.E., et al. Atheromatous plaque cap thickness can be determined by quantitative color analysis during angioscopy: implications for identifying the vulnerable plaque. Clin Cardiol 27 (2004) 9-15
21. Kubo T., Imanishi T., Takarada S., et al. Implication of plaque color classification for assessing plaque vulnerability. J Am Coll Cardiol Intv 1 (2008) 74-80
22. Cutlip D.E., Chhabra A.G., Baim D.S., et al. Beyond restenosis: five-year clinical outcomes from second-generation coronary stent trials. Circulation 110 (2004) 1226-1230
23. Grines C.L., Bonow R.O., Casey Jr. D.E., et al. Prevention of premature discontinuation of dual antiplatelet therapy in patients with coronary artery stents: a science advisory from the American Heart Association, American College of Cardiology, Society for Cardiovascular Angiography and Interventions, American College of Surgeons, and American Dental Association, with representation from the American College of Physicians. Circulation 115 (2007) 813-818
24. King III S.B., Smith Jr. S.C., Hirshfeld Jr. J.W., et al. 2007 focused update of the ACC/AHA/SCAI 2005 guideline update for percutaneous coronary intervention: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines: 2007 Writing Group to Review New Evidence and Update the ACC/AHA/SCAI 2005 Guideline Update for Percutaneous Coronary Intervention, Writing on Behalf of the 2005 Writing Committee. J Am Coll Cardiol 51 (2008) 172-209